PL1853220T3 - Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne - Google Patents

Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne

Info

Publication number
PL1853220T3
PL1853220T3 PL06709907T PL06709907T PL1853220T3 PL 1853220 T3 PL1853220 T3 PL 1853220T3 PL 06709907 T PL06709907 T PL 06709907T PL 06709907 T PL06709907 T PL 06709907T PL 1853220 T3 PL1853220 T3 PL 1853220T3
Authority
PL
Poland
Prior art keywords
nsaid
compositions
production process
medicinal use
containing lozenges
Prior art date
Application number
PL06709907T
Other languages
English (en)
Other versions
PL1853220T5 (pl
Inventor
Kirsty Sawicka
Jasmine Takhar
Paul Marshall
Michael Fanfarillo
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1853220(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of PL1853220T3 publication Critical patent/PL1853220T3/pl
Publication of PL1853220T5 publication Critical patent/PL1853220T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06709907.7T 2005-03-01 2006-02-27 Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne PL1853220T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504157A GB2423710A (en) 2005-03-01 2005-03-01 Lozenge production process
EP06709907.7A EP1853220B2 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use
PCT/GB2006/000680 WO2006092569A1 (en) 2005-03-01 2006-02-27 Production process for nsaid-containing lozenges, their compositions, their medicinal use

Publications (2)

Publication Number Publication Date
PL1853220T3 true PL1853220T3 (pl) 2018-01-31
PL1853220T5 PL1853220T5 (pl) 2023-08-07

Family

ID=34430399

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17185774T PL3284458T3 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek do ssania zawierających NLPZ
PL06709907.7T PL1853220T5 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek zawierających NLPZ, ich kompozycje, ich zastosowanie medyczne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17185774T PL3284458T3 (pl) 2005-03-01 2006-02-27 Sposób wytwarzania pastylek do ssania zawierających NLPZ

Country Status (21)

Country Link
US (2) US10328039B2 (pl)
EP (3) EP3284458B1 (pl)
JP (1) JP2008531664A (pl)
KR (2) KR20140011422A (pl)
CN (2) CN103156818A (pl)
AU (1) AU2006219777B2 (pl)
CA (1) CA2599861A1 (pl)
DK (1) DK1853220T3 (pl)
ES (2) ES2886323T3 (pl)
GB (1) GB2423710A (pl)
HU (1) HUE034872T2 (pl)
MX (1) MX2007009275A (pl)
MY (1) MY154770A (pl)
PL (2) PL3284458T3 (pl)
PT (1) PT1853220T (pl)
RU (1) RU2403032C2 (pl)
SG (1) SG161201A1 (pl)
SI (2) SI3284458T1 (pl)
TW (1) TWI372065B (pl)
WO (1) WO2006092569A1 (pl)
ZA (1) ZA200706067B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090104236A1 (en) * 2007-10-18 2009-04-23 Pharmaceutics International, Inc. Pharmaceutical solid hybrids
GB201215988D0 (en) * 2012-09-07 2012-10-24 Reckitt Benckiser Healthcare Int Ltd Pharmaceutical compositions comprising flurbiprofen
US9914968B2 (en) 2012-09-26 2018-03-13 Cepheid Honeycomb tube
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
KR20220050932A (ko) * 2019-08-22 2022-04-25 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 비-스테로이드성 항-염증 약물을 사용한 조성물 및 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1084864A (en) 1964-02-06 1967-09-27 Merck & Co Inc Medicated lozenges
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5028625A (en) * 1989-06-20 1991-07-02 American Home Products Corporation Acid addition salt of ibuprofen and meglumine
US5210099A (en) * 1991-02-11 1993-05-11 American Home Products Corporation Analgesic compositions
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9523833D0 (en) 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO1998052540A1 (en) 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
JP2004506680A (ja) * 2000-08-18 2004-03-04 ファルマシア・コーポレーション シクロオキシゲナーゼ−２阻害剤の迅速崩壊経口製剤
US6689382B2 (en) 2002-05-15 2004-02-10 Procaps S.A. Soft shell gelatin capsules containing non-steroidal anti-inflammatories
US20070190153A1 (en) † 2004-03-05 2007-08-16 Jonathan Farber Delivery systems for non-steroidal anti-inflammatory drugs (nsaids)

Also Published As

Publication number Publication date
WO2006092569A1 (en) 2006-09-08
EP3284458A1 (en) 2018-02-21
PL1853220T5 (pl) 2023-08-07
US10933040B2 (en) 2021-03-02
EP1853220B1 (en) 2017-08-16
AU2006219777A1 (en) 2006-09-08
GB0504157D0 (en) 2005-04-06
SI1853220T1 (sl) 2017-12-29
ES2647488T4 (es) 2024-01-16
HUE034872T2 (hu) 2018-03-28
EP2210587A1 (en) 2010-07-28
EP3284458B1 (en) 2021-06-16
PT1853220T (pt) 2017-11-17
MY154770A (en) 2015-07-15
SI1853220T2 (sl) 2023-07-31
GB2423710A (en) 2006-09-06
EP1853220A1 (en) 2007-11-14
ES2647488T3 (es) 2017-12-21
AU2006219777B2 (en) 2010-07-01
RU2403032C2 (ru) 2010-11-10
EP1853220B2 (en) 2023-03-29
TWI372065B (en) 2012-09-11
SG161201A1 (en) 2010-05-27
ES2886323T3 (es) 2021-12-17
JP2008531664A (ja) 2008-08-14
KR20070110053A (ko) 2007-11-15
SI3284458T1 (sl) 2021-11-30
US10328039B2 (en) 2019-06-25
KR101358687B1 (ko) 2014-02-07
US20080206326A1 (en) 2008-08-28
MX2007009275A (es) 2007-09-19
CA2599861A1 (en) 2006-09-08
RU2007136106A (ru) 2009-04-10
PL3284458T3 (pl) 2021-12-13
KR20140011422A (ko) 2014-01-28
ES2647488T5 (es) 2023-08-09
ZA200706067B (en) 2008-09-25
CN103156818A (zh) 2013-06-19
US20190307711A1 (en) 2019-10-10
DK1853220T3 (da) 2017-11-13
TW200716199A (en) 2007-05-01
CN101132762A (zh) 2008-02-27

Similar Documents

Publication Publication Date Title
TWI349657B (en) Process for producing dichloropropanol
DK3872059T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
TWI449540B (en) Process for the production of an abuse-proofed dosage form
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
IL184974A0 (en) Process for making (s)-pregabalin
EP1871363A4 (en) COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
EP1861408A4 (en) PROCESS FOR PRODUCING HYDROCHLOROSILANES
EP1874948A4 (en) PROCESS FOR THE PREPARATION OF Y-GLUTAMYLCYSTEIN
IL193341A0 (en) Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
GB0500604D0 (en) Novel process
GB0519758D0 (en) Novel process
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
GB0614245D0 (en) Synthesis process
GB0526474D0 (en) Novel process
ZA200706067B (en) Production process for NSAID-containing lozenges, their compositions, their medicinal use
EP2083003A4 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLOROBUTANE
IL187155A0 (en) Process for production of 4-biphenylazetidin-2-ones
IL185722A0 (en) Process for the production of methylcobalamin
PT1907118E (pt) Processo para a preparação de poliéter-aminas
HUP0501138A2 (en) Process for the production of a pharmaceutical intermediate
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
ZA200710066B (en) Process for production of 4-biphenylylazetidin-2-ones
EP1930310A4 (en) PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONALDEHYDE
EP1975146A4 (en) PROCESS FOR PRODUCING 1,6-HEXANEDIOL